Literature DB >> 20956273

Phenotypic variability in patients with retinal dystrophies due to mutations in CRB1.

Robert H Henderson1, Donna S Mackay, Zheng Li, Phillip Moradi, Panagiotis Sergouniotis, Isabelle Russell-Eggitt, Dorothy A Thompson, Anthony G Robson, Graham E Holder, Andrew R Webster, Anthony T Moore.   

Abstract

OBJECTIVES: To identify CRB1 mutations in a large cohort of patients with recessive retinal dystrophies and to document the retinal phenotype and visual prognosis.
DESIGN: A hospital-based cross-sectional study of children and adults with recessive retinal dystrophies. PARTICIPANTS: Three hundred and six patients with Leber congenital amaurosis (LCA), early-onset childhood retinal dystrophy or juvenile onset retinitis pigmentosa were recruited to the study and gave blood samples for molecular genetic analysis.
METHODS: A detailed clinical examination was performed, including: logMAR visual acuity, refraction, Goldmann visual fields, slit-lamp biomicroscopy, fundus photography, autofluorescence imaging and optical coherence tomography. The results of electrophysiology testing were available in all patients. DNA was obtained for molecular genetic analysis. Initial screening for mutations was performed using the LCA chip. Patients who had one or more CRB1 mutations identified on the chip, and other patients whose phenotype suggested a CRB1 genotype, underwent direct sequencing. In addition, consanguineous families segregating recessive RP underwent a whole genome scan using Affymetrix gene chips, and affected family members showing linkage to the RP12 locus underwent sequencing of the CRB1 gene. MAIN OUTCOME MEASURES: Identification of patients with mutations in CRB1 and detailed documentation of the clinical phenotype.
RESULTS: Mutations in CRB1, including 17 novel mutations, were identified in 41 patients from 32 families. The authors identified both disease mutations in 34 patients from 26 families, and these patients underwent detailed phenotyping. Common phenotypic features included hypermetropic refractive error, nummular pigmentation at the level of the RPE and increased retinal thickness on optical coherence tomography. Most patients had a clinical and electrophysiological phenotype consistent with a diagnosis of LCA or rod-cone dystrophy, but three patients had electroretinogram evidence of cone-rod degeneration. A minority of patients developed peripheral retinal telangiectasia, which in some cases led to seclusio pupillae and angle-closure glaucoma.
CONCLUSION: Mutations in CRB1 are associated with a range of recessively inherited retinal dystrophies, including LCA, childhood- and juvenile-onset rod-cone and cone-rod dystrophies. Although the phenotype is usually severe, in milder cases there is a window of opportunity for therapeutic intervention in early childhood.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20956273     DOI: 10.1136/bjo.2010.186882

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  46 in total

Review 1.  CRB1 mutations in inherited retinal dystrophies.

Authors:  Kinga Bujakowska; Isabelle Audo; Saddek Mohand-Saïd; Marie-Elise Lancelot; Aline Antonio; Aurore Germain; Thierry Léveillard; Mélanie Letexier; Jean-Paul Saraiva; Christine Lonjou; Wassila Carpentier; José-Alain Sahel; Shomi S Bhattacharya; Christina Zeitz
Journal:  Hum Mutat       Date:  2011-12-27       Impact factor: 4.878

2.  Human CRB1-associated retinal degeneration: comparison with the rd8 Crb1-mutant mouse model.

Authors:  Tomas S Aleman; Artur V Cideciyan; Geoffrey K Aguirre; Wei Chieh Huang; Cristina L Mullins; Alejandro J Roman; Alexander Sumaroka; Melani B Olivares; Frank F Tsai; Sharon B Schwartz; Luk H Vandenberghe; Maria P Limberis; Edwin M Stone; Peter Bell; James M Wilson; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-29       Impact factor: 4.799

3.  Functional principal component analysis reveals discriminating categories of retinal pigment epithelial morphology in mice.

Authors:  Yi Jiang; Xin Qi; Micah A Chrenek; Christopher Gardner; Jeffrey H Boatright; Hans E Grossniklaus; John M Nickerson
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-05       Impact factor: 4.799

Review 4.  Review and update on the molecular basis of Leber congenital amaurosis.

Authors:  Oscar Francisco Chacon-Camacho; Juan Carlos Zenteno
Journal:  World J Clin Cases       Date:  2015-02-16       Impact factor: 1.337

5.  Genetic ablation of Pals1 in retinal progenitor cells models the retinal pathology of Leber congenital amaurosis.

Authors:  Seo-Hee Cho; Jin Young Kim; David L Simons; Ji Yun Song; Julie H Le; Eric C Swindell; Milan Jamrich; Samuel M Wu; Seonhee Kim
Journal:  Hum Mol Genet       Date:  2012-03-07       Impact factor: 6.150

6.  Cytoglobin deficiency potentiates Crb1-mediated retinal degeneration in rd8 mice.

Authors:  Young Sam Kwon; Addy Tham; Antonio Jacobo Lopez; Sydney Edwards; Sean Woods; Jiajia Chen; Jenna Wong-Fortunato; Alejandra Quiroz Alonso; Seanne Javier; Ingrid Au; Maria Clarke; Devin Humpal; K C Kent Lloyd; Sara Thomasy; Christopher Murphy; Thomas M Glaser; Ala Moshiri
Journal:  Dev Biol       Date:  2019-10-18       Impact factor: 3.582

Review 7.  The Family of Crumbs Genes and Human Disease.

Authors:  Anne M Slavotinek
Journal:  Mol Syndromol       Date:  2016-08-18

8.  Whole exome sequencing identifies CRB1 defect in an unusual maculopathy phenotype.

Authors:  Stephen H Tsang; Tomas Burke; Maris Oll; Suzanne Yzer; Winston Lee; Yajing Angela Xie; Rando Allikmets
Journal:  Ophthalmology       Date:  2014-05-06       Impact factor: 12.079

9.  Mthfr as a modifier of the retinal phenotype of Crb1(rd8/rd8) mice.

Authors:  Shanu Markand; Alan Saul; Amany Tawfik; Xuezhi Cui; Rima Rozen; Sylvia B Smith
Journal:  Exp Eye Res       Date:  2015-12-02       Impact factor: 3.467

10.  Phenotypic features of CRB1-associated early-onset severe retinal dystrophy and the different molecular approaches to identifying the disease-causing variants.

Authors:  Bohdan Kousal; Lubica Dudakova; Renata Gaillyova; Michaela Hejtmankova; Pavel Diblik; Michel Michaelides; Petra Liskova
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-25       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.